Molecular profiling of CD34+ cells and granulocytes of MPN determined gene expression patterns beyond their recognized function in disease pathogenesis that included dominant up-regulation of PI3K/AKT signaling. The gene discussed is PIK3CA; the disease is myeloproliferative neoplasm.